Search
forResearch 10 of 1000+
- Repurposing of approved cardiovascular drugs
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- A perspective on small molecules targeting the renin–angiotensin–aldosterone system and their utility in cardiovascular diseases: exploring the structural insights for rational drug discovery and development
- Drugs and Hair Loss
- Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The metabolic effects of drugs used for the treatment of polycystic ovary syndrome
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- The use of anabolic androgenic steroids: A focus on polypharmacy
Community 4 of 21
- Finasteride is Good for Heart Health!
- Can RU58841 stop hairloss for a long time?
- Pattern hair loss before the age of 35 is associated with higher chances of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life
- Has anyone figured out what causes the cardiovascular issues with RU?